Atinum Investment Co., Ltd Overview
Atinum Investment is one of Korea's first-generation independent venture capital firms. It is also one of the very few listed Korean VCs whose economics depend on a small number of very large flagship funds. Its "one-fund" model concentrates the firm on a single blind-pool vehicle at a time, sized well above the Korean norm:
-
KRW 203bn (2014)
-
KRW 350bn (2017/18)
-
KRW 550bn (2020)
-
KRW 860bn (2023), the largest venture fund ever raised in Korea
-
A planned vehicle of up to KRW 1tn (2026)
These funds back companies from Series A through pre-IPO. The firm then follows on repeatedly, a pattern that produced Korea's most celebrated VC outcome: an early-2016 Dunamu (Upbit) investment at a valuation of about KRW 50bn, partly exited in 2022 at more than 100x.
The listed company earns management fees, carried interest and equity-method gains on its general-partner commitments. Profits are therefore highly cyclical and tied to exit timing. It is debt-free, controlled by founder Lee Min-joo's family office, and has received no sell-side research coverage in more than a decade.
What the company does
Atinum is a licensed venture capital company (창업투자회사). It does four things:
-
Raises blind-pool venture funds (투자조합) from institutional limited partners (LPs).
-
Acts as general partner (GP) and investment manager of those funds.
-
Commits its own balance-sheet capital to them as the GP commitment.
-
Invests a smaller amount of proprietary capital in other managers' funds and direct securities.
Its anchor LPs have been:
-
The National Pension Service (NPS), which by August 2022 had committed to Atinum funds nine times [Asiae, 2022-08-18].
-
Korea Development Bank (KDB). For Growth Fund 2023, KDB committed about KRW 160bn and NPS about KRW 150bn [Dealsite, 2026-07-17].
Revenue model
| Revenue component | Nature | Behaviour |
|---|---|---|
| Fund management fees (조합관리보수) | Recurring fee, a percentage of committed or invested capital | Stable floor. KRW 16.4bn (2021), 15.1bn (2022), 16.0bn (2023), 24.9bn (2024) [Dealsite, 2024-04-12 and 2025-03-12] |
| Performance fees / carried interest (조합성과보수) | Share of fund profits above the hurdle (10% IRR on the 2014 High Growth fund) | Lumpy; concentrated at fund maturity or liquidation. KRW 0 (2021), 113.2bn (2023), 22.0bn (2024) [Dealsite] |
| Equity-method income on GP commitments (조합지분법이익) | Atinum's pro-rata share of fund mark-to-market gains | Volatile and market-driven. KRW 17.5bn (2020), 96.5bn (2021), 3.7bn (2023), 1.1bn (2024) [Dealsite, 2022-05-13 and 2025-03-12] |
| Other operating revenue | Fair-value gains on directly held financial assets, dividends, interest | Small. KRW 3.6bn in FY2025 (financial-instrument gains 2.99bn + dividends 0.57bn) [Valueline] |
The company has a single business (venture capital fund management and investment). Its operating revenue has four components:
In terms of product type, revenue is effectively 100% service revenue (asset-management fees plus investment returns). There is no product, subscription or licensing revenue.
Value-chain position, customers and end-markets
| Sector team | Leader | Focus |
|---|---|---|
| Deep tech | Maeng Doo-jin | AI, semiconductors, robotics, batteries, smart factories, autonomous driving, humanoids |
| Service / Platform | Kim Je-wook | Fintech/crypto, commerce, marketplaces, B2B SaaS, LLMs |
| Bio / Healthcare | Kwak Sang-hoon | ADC, biologics, platform biotech |
| Games / Content | Park Sang-ho | Mobile and PC games, entertainment |
Value-chain position. Atinum sits between capital providers and private companies:
Upstream: institutional LPs, including NPS, KDB, the Korea Fund of Funds, the Yellow Umbrella mutual aid fund (approached in 2022), banks and securities firms.
Downstream: private, venture-backed companies, mainly in Korea.
Customers. There are two customer groups:
-
LPs, who pay fees.
-
Portfolio companies, who receive capital and value-add support.
End-markets for its investments, by sector team (from June 2025) [Asiae, 2025-06-30]:
Company's own description
The company's DART business report describes it as a venture capital company running a single venture-investment business.
The firm's English-language profile (reproduced on investor-directory sites and evidently dating from about 2016) says three things, paraphrased:
-
Its philosophy is to identify the intrinsic value of venture companies using sector specialists.
-
At that time it had invested in about 350 companies, formed 24 funds and liquidated 19.
-
It managed 5 funds with operating assets of about KRW 500bn.
These figures are dated and materially understate current scale [PrivateEquityList profile].
Independent characterisation
Atinum is best understood as a listed GP with a concentrated, vintage-driven earnings profile.
The fee floor has stepped up. The KRW 860bn 2023 fund lifted the recurring fee floor to about KRW 25bn a year. That is close to the firm's general and administrative costs excluding bonuses.
Profit swings come from two things:
-
Carried interest crystallising when funds mature.
-
Equity-method revaluations of the GP stakes.
The GP stake in Growth Fund 2023 is 8.78%, or roughly KRW 75bn of commitment (analyst calculation from the reported percentage).
Compensation is formula-driven. The bonus pool is 3% of realised gains after cost of capital. As a result, much of each carry windfall flows directly to the deal team [Dealsite, 2025-03-18].
Three structural features distinguish it from listed peers:
-
Unusually large single-fund size.
-
Long holding periods with repeated follow-ons. Examples: CLO Virtual Fashion (2014–2024/25) and Dunamu (2016–2022).
-
A stated practice of early interim distributions. Growth Fund 2023 had distributed 35% of paid-in capital by year 2.5.
Strategy
Stated corporate strategy (themes)
-
Large "one-fund" model. Concentrate investing capacity in a single flagship fund until it is deployed, then raise a larger successor about every three years. The aim is to fund portfolio companies from Series A through pre-IPO with repeated follow-ons, rather than spread effort across many small funds [Asiae, 2025-06-30; Dealsite, 2022-05-31].
-
Sector-head structure. Separate leaders for Deep Tech, Service/Platform, Bio and Games, intended to reduce staff spread and LP conflicts of interest [Asiae, 2025-06-30].
-
Exit discipline and early distributions (DPI focus). Mix long-horizon growth bets with growth-stage companies expected to produce visible results within two to three years. The company says most of its funds above KRW 100bn began interim distributions within about 2.5 years [Dealsite, 2025-12-23].
-
Follow-on concentration. Management said in November 2025 that it would favour repeated follow-ons into existing portfolio companies over adding many new names [Unicorn Factory, 2025-11-19].
-
Global expansion. US and Japan across all teams; Israel for technology; Türkiye and China for games. Global fundraising is led by Lee Seung-yong [Asiae, 2025-06-30; Dealsite, 2026-02-04].
-
Leadership continuity. The three-CEO structure is presented as a way to hand leadership to internal practitioners while preserving the firm's "investment DNA" [Dealsite, 2026-02-04].
Initiatives announced in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Detail | Source |
|---|---|---|---|
| Growth Fund 2023 interim distribution | Dec 2025 | About KRW 180bn (35% of paid-in) distributed; DPI 0.35x vs a 0.02x average for top-decile 2023-vintage funds cited by the company | Dealsite, 2025-12-23 |
| Three co-CEO structure | Feb–Mar 2026 | See Section 9.4 | Dealsite, 2026-02-04 |
| Corporate Value-up Plan (voluntary disclosure, 기업가치제고계획) | 19 Mar 2026 | Filed with KRX. Targets and payout commitments should be read from the original KIND filing before relying on them | Butler.works disclosure list |
| National Growth Fund GP (large league) | 27 May 2026 | Must form a fund of at least KRW 500bn; KDB anchor about KRW 200bn; competitors in the league included Korea Investment Partners, Dominus and Skylake | Asiae, 2026-05-27; Dealsite, 2026-06-08 |
| NPS venture-fund GP (large category) | 9 Jul 2026 | Up to about KRW 150bn | Dealsite, 2026-07-10 and 2026-07-17 |
| Next flagship (up to KRW 1tn) | 2026, close by year-end | Fundraising described as largely complete; the company was choosing among oversubscribed private LPs | Dealsite, 2026-07-17 |
| Accelerated deployment of Growth Fund 2023 | H1 2026 | KRW 183.2bn into 19 companies, more than the KRW 149.5bn invested in all of 2025. Tickets mostly KRW 5bn or more; includes mezzanine | Dealsite, 2026-07-29 |
| Brand-protection programme | 2025–26 | Anti-impersonation monitoring of about 32,000 brand exposures a year with vendor MarqVision, responding to investment-phishing scams using the Atinum name | MarqVision case study |
Sustainability / ESG commitments
No formal ESG targets were identified.
Cost programmes
No formal programme has been announced. Operating expenses fell 66% in FY2024 (KRW 111.0bn to 38.2bn), mainly through lower bonus accruals and equity-method losses [Dealsite, 2025-03-12].
Medium-term targets and guidance
Not publicly disclosed. The company does not issue earnings guidance.
The only quantified forward-looking items found are:
-
The next fund's size (hard cap KRW 1tn; minimum KRW 500bn under National Growth Fund terms).
-
The historical 15% target IRR for its scale-up fund [Asiae, 2021-04-27].
Products & Services
Atinum's "products" are its investment vehicles. The catalog below lists every vehicle identified, followed by the proprietary fund-of-funds positions and the named portfolio companies, which are the "flagship offerings" through which returns are generated.
Flagship blind-pool funds (GP role)
| Fund | Vintage / formation | Committed size (KRW Bn) | Atinum GP stake | Status (Oct 2026) | Key facts |
|---|---|---|---|---|---|
| Atinum New Paradigm Investment Fund (에이티넘뉴패러다임투자조합) | — | — | — | Harvesting; crossed its hurdle and paid carry in H1 2025 | Named as one of two funds that generated KRW 17.0bn of H1 2025 carry [Asiae, 2025-08-18] |
| Atinum High Growth Investment Fund (에이티넘고성장기업투자조합) | Mar 2014 | 203.0 | — | Liquidated (Mar 2026 per Asiae; Dealsite in Mar 2025 had expected Sep 2025) | 10% hurdle. Lead manager Hwang Chang-seok; key manager Kim Je-wook. Total distributions KRW 1,003.9bn; net IRR 29.8%; total carry KRW 218.7bn. Portfolio: Dunamu, Zigbang, Kakao Games, Pearl Abyss, LigaChem, Intocell, CLO [Dealsite, 2024-04-10; Asiae, 2026-08-24] |
| Atinum Growth Fund 2018 (에이티넘성장투자조합2018) | 2017 (vintage 2018) | 350.0 | 5.80% | Harvesting | Third mega-fund [DART FY2025 via ETF Shopping; Dealsite, 2024-04-10] |
| Atinum Growth Fund 2020 (에이티넘성장투자조합2020) | Dec 2020 | 550.0 | 3.82% | Harvesting; matures Dec 2028 | Largest Korean venture fund at formation. Generated about KRW 9.26bn of fees in 2021, over half the firm's fee base that year [Dealsite, 2022-05-13] |
| Atinum Growth Fund 2023 (에이티넘성장투자조합2023) | Sep or Dec 2023 | 860.0 | 8.78% | Investing | Lead manager Kim Je-wook. Anchors KDB (about KRW 160bn) and NPS (about KRW 150bn). KRW 516bn (60%) called in three calls by Dec 2025. Distributions KRW 180bn+ (DPI 0.35x). 44.3% deployed (Nov 2025); about 70% deployed (Jul 2026). Sole vehicle used in H1 2026 (19 companies, KRW 183.2bn) [Dealsite, 2025-12-23, 2026-07-17, 2026-07-29; Unicorn Factory, 2025-11-19] |
| Next flagship (name not disclosed; reported as up to KRW 1tn) | Target close by end-2026 | Hard cap 1,000; minimum 500 under National Growth Fund rules | — | Fundraising; reported as "past the 90% mark" in Jul 2026 | KDB / National Growth Fund anchor about KRW 200bn; NPS up to KRW 150bn; major banks and brokers each offering about KRW 50bn [Dealsite, 2026-07-17] |
| Parameter | Target |
|---|---|
| Deep tech (AI, big data, cloud) | 15–20% |
| Smart manufacturing (semiconductors, future mobility, robotics) | 10–15% |
| Innovative services / platforms | 35–45% |
| Bio / healthcare | 20–30% |
| Early-stage tickets | 20% of fund, about KRW 2bn each |
| First growth-stage tickets | 40% of fund, about KRW 5bn each |
| Second growth-stage tickets | 40% of fund, about KRW 10bn each |
| Target IRR | 15% |
| Fund term | 8 years, staged capital calls |
Earlier stated portfolio-construction template. An April 2021 Asiae report on the scale-up flagship then being upsized (timing consistent with Growth Fund 2020) set out the following:
[Asiae, 2021-04-27]
Proprietary LP commitments to third-party funds
| Vehicle | Manager / region | Atinum stake |
|---|---|---|
| Stonebridge DX Business Restructuring Investment Fund | Stonebridge Ventures (Korea) | 5.00% |
| Stonebridge-Shinhan Unicorn Secondary Fund | Stonebridge Ventures (Korea) | 8.45% |
| IMM Secondary Venture Fund No.5 | IMM Investment (Korea) | 6.67% |
| Base Distring Venture Fund (베이스디스트링벤처조합) | Korea | 6.25% |
| Primer Sazze Fund II | Primer (Korea/US) | 2.98% |
| Vertex Ventures SEA Fund III | Vertex (Southeast Asia) | 1.19% |
| Vertex Ventures SEA Fund IV | Vertex (Southeast Asia) | 0.82% |
| Openspace Ventures III L.P. | Openspace (Southeast Asia) | 1.25% |
| GFT Ventures I, LP | GFT (US) | 2.18% |
These are balance-sheet investments, not GP products. Stakes are at end-2025 [DART FY2025 via ETF Shopping].
Named portfolio companies, by sector
| Company | Description | Status |
|---|---|---|
| Dunamu | Operator of the Upbit crypto exchange. First invested 2016 at about KRW 50bn valuation; valuation reached KRW 20tn in 2021 | Partially exited 2022 at more than 100x [Dealsite] |
| Zigbang | Real-estate platform | Exited / harvested via High Growth fund |
| PRND Company (HeyDealer) | Used-car selling platform; KRW 10tn cumulative transaction value and 10M downloads by 2023; more than 50% share of "sell my car" | Active [Asiae, 2025-06-30] |
| Allganize | Enterprise lightweight LLM and RAG; Korea/US/Japan | Pursuing a Tokyo Stock Exchange listing [Asiae, 2025-06-30] |
| CLO Virtual Fashion | 3D garment simulation (CLO, Marvelous Designer); users include Hugo Boss, Nike, H&M, Levi's | Fully exited at about 23x; enterprise value KRW 600–700bn at exit [Asiae, 2026-08-24] |
| Healingpaper (Gangnam Unni) | Cosmetic-procedure platform | Active [Asiae, 2026-08-24] |
| Bungaejangteo | Second-hand marketplace | Active [Asiae, 2026-08-24] |
| Craver Corporation (SKIN1004) | K-beauty brand; revenue about KRW 650bn; sold for about KRW 245.6bn | Exited 2025 [Dealsite, 2026-02-10] |
| Slickflow | Omnichannel communications SaaS; Atinum led its USD 7M (about KRW 9.7bn) Series A in Q3 2024 | Active [Dealsite, 2024-11-07] |
| Psionic AI | AI; KRW 25bn Series A (Dec 2025), co-invested with IMM, KIP, Mirae, Samsung Ventures | Active [TheVC] |
| Aurum Planet | Platform | Active (new Q3 2024) [Dealsite, 2024-11-07] |
| Company | Description | Status |
|---|---|---|
| RideFlux | Autonomous driving; first Korean permit for driverless test operation | Targeting KOSDAQ listing [Asiae, 2025-06-30] |
| Holiday Robotics | Humanoid / collaborative robotics | New in Q3 2024; follow-on rounds [Dealsite, 2024-11-07; TheVC] |
| Exyna (엑시나) | Deep tech | Core holding [Asiae, 2026-08-24] |
| Company | Description | Status |
|---|---|---|
| LigaChem Biosciences | ADC biotech | Harvested |
| Medytox | Toxins | Harvested (historic) |
| Celltrion | Biologics | Historic holding |
| Olix | RNAi | Historic / active |
| KoBioLabs | Microbiome | Historic / active |
| Intocell | ADC platform; licensing deals with Samsung Bioepis and ABL Bio | Listed May 2025; Atinum held 4.77% after partial sale |
| ABL Bio | Bispecific antibodies; licensing deal with Eli Lilly of about KRW 3.7tn | Partial exit at nearly 6x [Dealsite, 2026-02-10] |
| G2GBio | Long-acting injectables | Listed Aug 2025; more than 7x on the position |
| NexI (넥스아이) | Biotech | Core holding [Asiae, 2026-08-24] |
| BioDesignLab | Biotech | New Q3 2024 |
| Company | Description | Status |
|---|---|---|
| Kakao Games | Game publisher; early investment with stage-by-stage follow-ons | Exited |
| Pearl Abyss | Game developer; early investment with stage-by-stage follow-ons | Exited |
| Mondayoff | Hyper-casual mobile game publisher; 200M cumulative downloads by 2023 | Active |
| Lordcomplete | Developer of Crusaders Quest and Legend of Slime | Active |
| Blast | Games / content | Core holding |
| The Grim Entertainment | Games / content | Core holding |
Service / Platform
Deep tech
Bio / Healthcare
Games / Content
[Asiae, 2025-06-30 and 2026-08-24 unless otherwise noted]
Pricing model. Fee rates and carry percentages for each fund are not publicly disclosed. The only disclosed term is the 10% IRR hurdle on the High Growth fund.
Financial Narrative
Income statement (standalone K-IFRS)
[DART business reports FY2021–FY2025 via ETF Shopping; DPS from DART dividend filings via ETF Shopping; margins are analyst calculations]
Gross profit / gross margin: not applicable: The company does not present cost of sales. Aggregators show "cost of revenue" of KRW 34.4bn (FY2021) and 65.8bn (FY2022); these are fund-related operating expenses, not cost of goods sold.
EBITDA: Depreciation (mainly right-of-use assets) was about KRW 1.19bn in FY2025 [Valueline]. FY2025 EBITDA is therefore about KRW 33.2bn (EBITDA margin about 47.0%, analyst calculation).
Pre-tax income: FY2025 income tax expense was KRW 7.08bn, so pre-tax income was about KRW 32.2bn (effective tax rate about 22.0%) [Valueline; analyst calculation].
Longer-run earnings context (FY2016–FY2020)
[DART via ETF Shopping]
Balance sheet (standalone)
[Valueline standalone balance sheet, FY2022–FY2025; working capital and net debt are analyst calculations]
Interim position at 30 June 2026:
-
Total assets KRW 201.6bn; cash KRW 32.4bn; equity-method fund interests KRW 91.4bn
-
Total liabilities KRW 3.6bn; equity KRW 198.0bn
-
Current assets KRW 46.5bn; current liabilities KRW 3.4bn
[Valueline]
-
FY2021 balance sheet.
-
Goodwill: none recorded.
-
Short/long-term debt split: not applicable, as there is no financial debt.
-
Treasury stock: carried within "other capital" at −KRW 7.53bn (FY2023–FY2025) and −KRW 4.82bn (FY2022).
Cash flow
FY2025 (Valueline trailing-12-month column at December 2025, equal to the fiscal year):
Trailing 12 months to June 2026: operating cash flow KRW 3.6bn; dividends paid KRW 6.43bn [Valueline].
Shareholder returns history:
[DART via ETF Shopping. The FY2025 declared figure reflects the initial decision of about KRW 6.0bn; actual paid was about KRW 6.43bn, a 25.6% payout.]
Ratios
[Analyst calculations from DART/Valueline data]
Quarterly earnings (most recent 10 quarters)
[DART quarterly and semi-annual reports via ETF Shopping]
H1 2026 vs H1 2025:
-
Revenue: KRW 10.6bn vs KRW 30.5bn
-
Operating profit: −KRW 0.8bn vs +KRW 13.3bn
-
Net income: −KRW 0.1bn vs +KRW 10.5bn
Trailing-12-month figures to June 2026 (analyst calculations): revenue about KRW 50.7bn; operating profit about KRW 17.9bn; net income about KRW 14.5bn, which matches Valueline's KRW 14.46bn.
Commentary: trends, inflections and drivers
1. FY2021 peak. The 352% net-income jump came almost entirely from marking the High Growth fund (Dunamu, Kakao Games, Pearl Abyss) to market. The fund contributed KRW 83.1bn of the firm's KRW 96.5bn equity-method gain. No carry was booked that year because no fund was liquidated [Dealsite, 2022-05-13].
2. FY2022–FY2023: cash realisation. Unrealised gains turned into cash carry: KRW 113.2bn of carry in FY2023. That was offset by large bonus accruals and KRW 37.1bn of equity-method losses as Korean growth-stock valuations fell. The bonus formula is 3% of realised gains after cost of capital. Kim Je-wook alone received KRW 28.3bn (2022) and KRW 21.1bn (2023). Bonuses explain why operating margin compressed to 18% in the record-revenue year.
3. FY2024: the floor. With little carry, revenue fell 62%. Management fees from the new KRW 860bn fund (+56%) and a 66% cut in operating expenses (to KRW 38.2bn) kept the company solidly profitable. This demonstrates the downside resilience of the fee base.
4. FY2025: inflection up. Exits (ABL Bio partial, SKIN1004/Craver, G2GBio, Intocell) and portfolio markups drove equity-method gains. Operating profit rose 137% and the cash balance more than doubled to KRW 63.2bn.
5. H1 2026: inflection down. Q2 2026 revenue of KRW 2.2bn was below the quarterly management-fee run-rate, which implies net negative fund income in the quarter (equity-method or fair-value losses). Valueline's trailing cash-flow detail at June 2026 shows equity-method losses of KRW 6.85bn and FVTPL valuation losses of KRW 3.80bn. Butler.works reports the Q2 revenue mix as 54% "other operating revenue" and 46% fund revenue.
Analyst view: Q2 likely reflected portfolio markdowns and the absence of carry rather than any deterioration in the fee base. Liabilities collapsed to KRW 3.6bn as accrued bonuses and taxes were paid. The company has not published a reason.
6. Balance-sheet strength. The company has carried no financial debt in any year shown. Equity of KRW 198bn (June 2026) compares with a market capitalisation of about KRW 89bn. Of that equity, roughly KRW 145bn is fund interests and financial assets, and KRW 32bn is cash.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment (KRW) and Segment Margins & Growth (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Operating revenue (KRW 100M) | 1,358 | 517 | 706 |
Operating profit (KRW 100M) | 248 | 135 | 320 |
Operating margin (%) | 18.3 | 26.1 | 45.3 |
YoY revenue growth (%) | 34.5 | -61.9 | 36.4 |
Share of total revenue (%) | 100 | 100 | 100 |
Revenue type (KRW 100M)
| Revenue type (KRW 100M) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Fund-related revenue (투자조합수익), total | 1,329 | 480 | 670 |
Other operating revenue (financial-instrument gains, dividends, interest) | 29 | 37 | 36 |
Total operating revenue | 1,358 | 517 | 706 |
Fund-revenue component (KRW 100M)
| Fund-revenue component (KRW 100M) | FY2023 | FY2024 |
|---|---|---|
Management fees | 160 | 249 |
Performance fees (carried interest) | 1,132 | 220 |
Equity-method income from funds | 37 | 11 |
Components
| Component | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Management fees | 88 | 164 | 151 | 160 | 249 |
Income Statement (KRW) and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating revenue (KRW 100M) | 1,176 | 1,010 | 1,358 | 517 | 706 |
Operating profit (KRW 100M) | 832 | 352 | 248 | 135 | 320 |
Net income (KRW 100M) | 660 | 282 | 201 | 108 | 251 |
EPS basic (KRW) | 1,380 | 600 | 434 | 236 | 545 |
Dividend per share (KRW) | 200 | 150 | 120 | 70 | 140 |
Operating margin (%) | 70.7 | 34.9 | 18.3 | 26.1 | 45.3 |
Net margin (%) | 56.1 | 27.9 | 14.8 | 20.9 | 35.6 |
Revenue growth YoY (%) | 265.4 | -14.1 | 34.5 | -61.9 | 36.4 |
CAGR by Period
| Period | CAGR | Comment |
|---|---|---|
FY2021–FY2025 | -12.0% | Distorted by the FY2021 equity-method peak |
FY2020–FY2025 | +17.0% | FY2020 revenue KRW 32.2bn; better reflects the step-up in fund scale |
Income Statement (KRW) and Per-Share Data (FY2016–FY2020)
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
Operating revenue (KRW 100M) | 132 | 251 | 171 | 214 | 322 |
Operating profit (KRW 100M) | 67 | 123 | 80 | 85 | 172 |
Net income (KRW 100M) | 54 | 87 | 70 | 67 | 146 |
Dividend per share (KRW) | 35 | 60 | 50 | 50 | 100 |
Balance Sheet (KRW)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Total assets (KRW 100M) | 1,945.9 | 2,227.3 | 2,168.4 | 2,251.6 |
Cash and cash equivalents (KRW 100M) | 318.1 | 251.0 | 275.5 | 631.9 |
Equity-method fund interests (KRW 100M) | 968.1 | 759.7 | 768.1 | 839.0 |
FVTPL financial assets, non-current (KRW 100M) | 516.4 | 586.2 | 607.3 | 542.3 |
Accrued income incl. accrued fees and carry (KRW 100M) | 82.8 | 571.0 | 435.9 | 160.1 |
Intangible assets (KRW 100M) | 36.1 | 36.1 | 63.5 | 63.5 |
Total borrowings, short plus long (KRW 100M) | 0 | 0 | 0 | 0 |
Total liabilities (KRW 100M) | 276.1 | 454.2 | 342.1 | 206.5 |
Total equity (KRW 100M) | 1,669.8 | 1,773.0 | 1,826.3 | 2,045.0 |
Retained earnings (KRW 100M) | 1,416.7 | 1,547.0 | 1,600.3 | 1,819.0 |
Current assets (KRW 100M) | 402.0 | 823.2 | 717.5 | 795.8 |
Current liabilities (KRW 100M) | 159.6 | 244.4 | 291.0 | 199.4 |
Working capital (KRW 100M) | 242.4 | 578.8 | 426.5 | 596.4 |
Net debt, negative = net cash (KRW 100M) | -318.1 | -251.0 | -275.5 | -631.9 |
Financial Analysis
| Item | KRW 100M |
|---|---|
Operating cash flow | 397.6 |
Capital expenditure (PP&E) | about 0.1 |
Free cash flow (analyst calculation) | about 397.5 |
Lease and other financing outflows | 10.2 |
Dividends paid (FY2024 dividend, paid Apr 2025) | 32.2 |
Share buybacks | 0 |
Income taxes paid | 77.1 |
Dividends & Capital Returns (KRW) and Returns & Leverage Ratios (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividends declared for the year (KRW 100M) | 95 | 70 | 55 | 32 | 60 |
Treasury share purchases in the year (KRW 100M) | 14 | 34 | 27 | 0 | 0 |
Payout ratio, dividends / net income (%) | 14 | 25 | 27 | 30 | 24 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
ROE on year-end equity (%) | 16.9 | 11.3 | 5.9 | 12.3 |
ROA on year-end assets (%) | 14.5 | 9.0 | 5.0 | 11.1 |
Current ratio (x) | 2.52 | 3.37 | 2.47 | 3.99 |
Liabilities to equity (%) | 16.5 | 25.6 | 18.7 | 10.1 |
Asset turnover (x) | 0.52 | 0.61 | 0.24 | 0.31 |
Financial Analysis — Debt to equity
| Ratio | Value | Note |
|---|---|---|
Debt to equity | 0.0x in all years | No borrowings |
Net debt to EBITDA | Negative (net cash) | FY2025 net cash is about 19x EBITDA |
Interest coverage | More than 300x | FY2025 interest expense about KRW 0.09bn (lease interest) vs operating profit of KRW 32.0bn; not meaningful |
ROIC, FY2025 | About 17.7% | NOPAT about KRW 25.0bn (operating profit × 78%) ÷ (equity − cash) of about KRW 141.3bn (analyst calculation) |
Financial Analysis — Operating revenue
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|
Operating revenue (KRW 100M) | 72 | 93 | 90 | 262 | 67 | 238 | 242 | 159 | 84 | 22 |
Operating profit (KRW 100M) | 34 | 34 | 28 | 39 | 22 | 111 | 182 | 6 | 43 | -51 |
Net income (KRW 100M) | 25 | 31 | 22 | 31 | 16 | 89 | 147 | -2 | 33 | -34 |
Region Assets & Liabilities (KRW)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Revenue attributed to Korea-domiciled funds and assets (KRW 100M, analyst inference) | 1,358 | 517 | 706 |
Valuation Multiples (KRW) and Valuation Multiples (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Year-end share price (KRW) | 2,620 | 3,585 | 2,160 | 2,870 |
Year-end market cap on 48.0M shares (KRW 100M) | 1,257.6 | 1,720.8 | 1,036.8 | 1,377.6 |
P/E at year-end (x) | 4.4 | 8.3 | 9.2 | 5.3 |
P/B at year-end (x) | 0.75 | 0.97 | 0.57 | 0.67 |
Dividend yield at year-end (%) | 5.7 | 3.3 | 3.2 | 4.9 |
Share Price & Returns
| Period | Return | Basis |
|---|---|---|
1 year | −23.3% | To 8 Oct 2026, at KRW 2,025 [ETF Shopping] |
Year to date | About −35.3% | End-2025 KRW 2,870 to 15 Oct 2026 KRW 1,857 (analyst calculation) |
6 months | −29.9% | To 8 Oct 2026 [ETF Shopping] |
About 3 years | About −48.2% | End-2023 KRW 3,585 to KRW 1,857 (analyst calculation) |
About 4 years | About −29.1% | End-2022 KRW 2,620 to KRW 1,857 (analyst calculation) |
Valuation Snapshot
| Multiple | Value | Inputs |
|---|---|---|
P/E, FY2025 | 3.4x | EPS KRW 545 |
P/E, trailing 12 months to Jun 2026 | About 6.2x | Net income about KRW 14.5bn |
P/B | About 0.45x | June 2026 equity KRW 198.0bn |
EV | About KRW 56.7bn | Market cap KRW 89.1bn − cash KRW 32.4bn; no debt |
EV/Sales, trailing 12 months | About 1.1x | Revenue about KRW 50.7bn |
EV/EBITDA, trailing 12 months | About 3.0x | Operating profit about KRW 17.9bn + D&A about KRW 1.1bn |
Dividend yield | About 7.5% | FY2025 DPS KRW 140 |
Peer Comparison
| Peer | P/E | Dividend yield |
|---|---|---|
Mirae Asset Venture Investment | 25.7x | 0.00% |
Woori Technology Investment | 4.4x | 0.00% |
Dividend per share (KRW)
| Dividend per share (KRW) | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
DPS | 35 | 60 | 50 | 50 | 100 | 200 | 150 | 120 | 70 | 140 |
Analyst Conclusions
Management guidance
None issued. Implicit forward markers are:
-
Closing the new flagship (up to KRW 1tn) by end-2026.
-
Continued deployment of Growth Fund 2023, about 70% invested by July 2026 [Dealsite, 2026-07-29].
-
Continued interim distributions.
Consensus growth expectations
None available (no coverage).
Bull case
-
Fee-base step-up. A first close near KRW 1tn would roughly double the flagship fee base relative to the 2023 fund at similar fee rates (analyst assumption; fee terms not disclosed). That would push recurring fees well above FY2024's KRW 24.9bn and make the firm structurally profitable before carry.
-
Carry pipeline. The 2018 (KRW 350bn) and 2020 (KRW 550bn) funds approach harvest. The 2023 fund is already at 0.35x DPI. If the firm repeats even part of the High Growth fund's 29.8% net IRR, carry could recur across 2027–2030.
-
Deep value with yield. About 0.45x book, about 3.0x EV/EBITDA, net cash of about KRW 32bn and an about 7.5% yield. Listed peers re-rated 3–5x in 2025–26 on portfolio enthusiasm while Atinum's shares fell, which leaves room for a catch-up if IR and value-up commitments improve.
Bear case
-
Quality of earnings. H1 2026 was roughly break-even, and Q2 2026 posted a loss on KRW 2.2bn of revenue. Without carry, equity-method marks can erase fee income in weak quarters, and the stock offers no guidance or coverage to anchor expectations.
-
Deployment and vintage risk. Investing more than KRW 1.4tn (the 2023 fund remainder plus the new fund) during an AI and deep-tech valuation upcycle, with larger tickets and mezzanine, raises the risk of a disappointing vintage. Under the one-fund model that would hit reputation and future fundraising at once.
-
Governance and people. Family control (33.46%), the founder's son-in-law as co-CEO, extreme pay concentration and a reported reward-imbalance departure may justify a permanent discount. Minority holders capture only part of carry economics: a 3% gain-sharing formula flows to staff, and the dividend payout is only about 25%.
Key catalysts and monitorables (next 12 months)
-
Final close, size and LP mix of the new flagship. The fee start date determines when FY2027 management fees step up.
-
Q3 2026 results (due by mid-November 2026) and FY2026 results (February/March 2027). Watch whether the Q2 equity-method losses reverse.
-
FY2026 dividend decision (expected February 2027) versus the Value-up Plan; any buyback or cancellation of the 4.18% treasury stake.
-
IPO or exit events in the portfolio: RideFlux (KOSDAQ), Allganize (TSE), HeyDealer, and further interim exits in the bio book.
-
Further DPI updates on Growth Fund 2023.
-
Talent stability: departures of senior investment professionals, and the bonus outcome for FY2026.
-
Return to the top-4 AUM ranking once the new fund is counted.
Concluding analyst verdict
Atinum Investment is a high-quality GP wrapped in an under-loved, illiquid listed shell.
The franchise case is strong and evidenced. The 2014 High Growth fund returned about five times committed capital with a 29.8% net IRR. The 2023 mega-fund produced a 0.35x DPI within two and a half years. In 2025 Atinum led all Korean VCs in exits. Its selection as the only VC in the National Growth Fund large league, ahead of the AUM leader Korea Investment Partners, together with a parallel NPS mandate, shows that the policy LPs who decide the top of this market regard it as one of a handful of houses capable of running a KRW 1tn venture fund.
The listed-equity case is more complicated. Shareholders own a stream of lumpy carry and volatile equity-method marks. A meaningful share of realised gains is paid away to the investment team by formula. Control sits with a founder family office holding a third of the company. The firm has gone more than a decade without sell-side coverage and has no guidance, and dividends have swung between KRW 70 and 200 per share.
Valuation. The market is pricing the shares at about 0.45x book and about 3x EV/EBITDA, with net cash covering more than a third of market value. That looks overly punitive given a debt-free balance sheet, an about 7.5% trailing yield and a fee base likely to step up materially once the new fund begins charging.
Verdict. Fundamentally undervalued but catalyst-dependent. The re-rating path runs through three things:
-
Closing the new fund.
-
A credible, quantified shareholder-return framework, ideally evidenced in the FY2026 dividend and any treasury-share cancellation.
-
Steadier quarterly reporting as fee income grows relative to marks.
Until then, investors should treat Atinum as a deep-value, high-volatility exposure to the Korean venture exit cycle rather than a compounding asset manager.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / background | 2025 total pay (KRW 100M) |
|---|---|---|---|
Shin Ki-cheon (신기천) | Co-CEO and Vice Chairman (대표이사 부회장); oversees overall management | Long-serving CEO (named CEO in Dealsite reporting since at least 2019). Holds 0.38% of shares. Remains active to support the leadership transition [Dealsite, 2026-02-10] | 27.6 |
Lee Seung-yong (이승용) | Co-CEO; overseas investment and global fundraising | Eldest son-in-law of founder Lee Min-joo [Dealsite, 2022-05-20] | 11.4 |
Maeng Doo-jin (맹두진) | Co-CEO (announced 4 Feb 2026, appointed after the Mar 2026 AGM); head of Deep Tech and domestic fundraising | PhD engineer, formerly Samsung Advanced Institute of Technology. Joined Atinum in Feb 2014 as an investment professional; more than 25 years in VC [Dealsite, 2026-02-04 and 2026-03-10] | 17.4 (as President) |
Kim Je-wook (김제욱) | Vice President (부사장); head of Service/Platform; lead manager of Growth Fund 2023 | BS Earth & Environmental Sciences and MS Computer Engineering, Seoul National University. Started at Samsung Electronics; joined Atinum 2010. Led Dunamu (2016) and CLO investments [Dealsite, 2025-12-09] | 103.0 |
Hwang Chang-seok (황창석) | President (사장) | Lead manager of the 2014 High Growth fund | 10.1 |
Kwak Sang-hoon (곽상훈) | Vice President; head of Bio | — | Below disclosure threshold |
Park Sang-ho (박상호) | Managing Director (전무); head of Games | — | Below disclosure threshold |
Lee Young-seop (이영섭) | Non-executive director (비상무이사) since Mar 2021 | Replaced founder Lee Min-joo on the board | — |
Lee Min-joo (이민주) | Founder; Chairman of Atinum Partners (controlling shareholder) | Resigned as registered director of Atinum Investment in Nov 2020 | Not applicable |
Directors' Remuneration
| Executive pay (KRW 100M) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Kim Je-wook, total | 282.6 | 210.9 | 78.8 | 103.0 |
Directors' Remuneration (FY2019–FY2021)
| Shin Ki-cheon pay (KRW 100M) | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
Total | 12.7 | 13.9 | 15.0 |
Board & Management Changes
| Date | Change | Source |
|---|---|---|
4 Feb 2026 | Maeng Doo-jin named third co-CEO. Roles split: Shin overall management; Lee global investment and fundraising; Maeng deep tech and domestic fundraising | Dealsite, 2026-02-04 |
Mar 2026 | Maeng formally appointed after the AGM and board meeting | Dealsite, 2026-02-04 and 2026-03-10 |
Early 2026 | Departure of Managing Director Park Eun-soo, a roughly 30-year Atinum veteran who handled internal administration and fundraising support | Dealsite, 2026-03-24 |
Major Shareholders
| Holder | Stake | Basis | Source |
|---|---|---|---|
Atinum Partners Co., Ltd. (founder's family office; real-estate leasing and management consulting) | 33.08% | 31 Dec 2025 | DART via ETF Shopping |
Shin Ki-cheon (CEO, related party) | 0.38% | 31 Dec 2025 | DART via ETF Shopping |
Largest shareholder plus related parties | 33.46% | 31 Dec 2025 | DART via ETF Shopping |
Treasury shares | About 4.18% | 2,026 | Butler.works |
Minority shareholders (15,044 holders) | 56.4% | 31 Dec 2025 | DART via ETF Shopping |
National Pension Service | 0.05% | 2021 year-end disclosure | ETF Shopping |
Park Young-ok (individual investor) | 7.21% | — | eToday, 2013-12-05 |
Competitive Landscape
Key Competitors
| Competitor | Listing | AUM / scale indicator | Relative positioning vs Atinum | Source |
|---|---|---|---|---|
Korea Investment Partners (한국투자파트너스) | Unlisted (Korea Investment Holdings) | AUM KRW 3,801.7bn (end-2025); KRW 3,892.1bn (H1 2026); No. 2 by 2025 exits (KRW 256.0bn) | Industry leader; lost to Atinum in the 2026 National Growth Fund large league | Dealsite, 2026-02-10 and 2026-06-08 |
KB Investment | Unlisted (KB Financial) | AUM KRW 2,512.4bn (end-2025) | Bank-affiliated, multi-fund | Dealsite, 2026-02-10 |
SBVA (formerly SoftBank Ventures Asia) | Unlisted | AUM KRW 2,291.6bn (end-2025) | Global LP base, early-stage tech | Dealsite, 2026-02-10 |
IMM Investment | Unlisted | AUM KRW 2,005.2bn (end-2025); overtook Atinum in H1 2026 | Frequent co-investor (CLO, Psionic AI); secondaries specialist | Dealsite, 2026-02-10 and 2026-07-14 |
Mirae Asset Venture Investment | KOSDAQ 100790 | 2025 revenue KRW 79.8bn, operating profit 33.9bn, net income 28.7bn (TheVC compilation; basis unclear). Asiae reported 9M 2025 revenue of KRW 126.0bn on a different basis | Largest listed VC by market value; SpaceX exposure re-rated its shares about 5x | TheVC; Asiae, 2025-11-17; IB Tomato |
DSC Investment | KOSDAQ 241520 | 2025 consolidated revenue KRW 41.5bn, operating profit 22.3bn | Early-stage deep tech (e.g. FuriosaAI); strong share re-rating | Unicorn Factory |
Woori Technology Investment | KOSDAQ 041190 | — | Crypto (Dunamu) exposure like Atinum; P/E about 4.4x | ETF Shopping |
Nau IB Capital | KOSDAQ | No. 1 by 2025 investment (KRW 437.9bn), including a cross-border semiconductor acquisition | M&A/restructuring hybrid | Dealsite, 2026-02-10 |
LB Investment | KOSDAQ 309960 | H1 2025 consolidated revenue KRW 12.1bn, operating profit 3.7bn | Former LG-affiliated multi-fund house | Asiae, 2025-08-18 |
Ajou IB Investment | KOSPI 027360 | — | Listed peer; shortlisted for the 2026 National Growth Fund small league | IB Tomato; Asiae, 2026-05-27 |
Skylake Equity Partners (PE) | Unlisted | Co-selected in the National Growth Fund large league | Competes for the same policy anchor capital | Asiae, 2026-05-27 |
Others: Intervest, Premier Partners, SL Investment, Partners Investment, TS Investment, Company K, SV Investment, Stonebridge Ventures | Mixed | — | Compete for NPS / Fund-of-Funds mandates; several were NPS 2026 GPs alongside Atinum | Dealsite, 2026-07-10 |
Peer Comparison FY2025
| Metric | Atinum Investment | Korea Investment Partners | Mirae Asset Venture | DSC Investment |
|---|---|---|---|---|
FY2025 operating revenue (KRW 100M) | 706 | — | 798 (TheVC; basis unclear) | 415 (consolidated) |
FY2025 operating profit (KRW 100M) | 320 | — | 339 (TheVC) | 223 |
FY2025 operating margin (%) | 45.3 | — | About 42.5 (calculated from TheVC) | About 53.7 (calculated) |
Revenue growth FY2025 (%) | 36.4 | — | 16.5 (TheVC) | — |
AUM end-2025 (KRW 100M) | 20,630 | 38,017 | — | — |
2025 exits (KRW 100M) | 3,113 | 2,560 | — | — |
Recent Developments
*Layoffs or hiring: Headcount fell from 59 (2024) to 50 (2025) in DART data.



